Benitec develops gene therapies for rare genetic diseases, led by a treatment candidate for oculopharyngeal muscular dystrophy. It last closed at $7.92 on Nov 20, down 2.76% on the day. The next earnings report for BNTC is expected around Thu, Feb 11, 2027. For the quarter ended Sep 2026, BNTC reported EPS of -$0.26. Over its last 8 reports the stock moved an average of 4.7% the session after earnings. Over the last 12 months BNTC insiders bought $2.4M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is BNTC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BNTC.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BNTCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BNTC · as of the Nov 20 close · updated each morning
Downtrend
The stock is 11% below its 20 day and 17% below its 50 day average. It is 43% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38). The nearest support is the swing low (Oct 28) at $7.88, and the nearest resistance the Pivot at $7.93.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 8.0%/day
Key levels
$14.3952 week high+81.7%
$11.28200 day average+42.4%
$10.95100 day average+38.3%
$9.2550 day average+16.8%
$9.11Swing high (Oct 29)+15.0%
$8.7920 day average+11.0%
$8.15Pivot R1+2.9%
$7.93Pivot+0.1%
$7.92Last close
$7.88Swing low (Oct 28)−0.5%
$7.7252 week low−2.5%
$7.70Pivot S1−2.8%
Indicators
RSI (14)
38.13
Weak, oversold below 30
Neutral
MACD
-0.28
Below its signal line
Bearish
Stochastic
9.3
Near the bottom of its range
Oversold
ADX (14)
24.1
Weak trend
Williams %R
-92.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-155.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−17.0%
Change over 10 sessions
Bearish
ATR (14)
$0.64
Typical daily range, 8.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 19.2%/day
Key levels
$14.3952 week high+81.7%
$11.28200 day average+42.4%
$10.95100 day average+38.3%
$9.2550 day average+16.8%
$9.11Swing high (Oct 29)+15.0%
$8.7920 day average+11.0%
$8.15Pivot R1+2.9%
$7.93Pivot+0.1%
$7.92Last close
$7.88Swing low (Oct 28)−0.5%
$7.7252 week low−2.5%
$7.70Pivot S1−2.8%
Indicators
RSI (14)
36.03
Weak, oversold below 30
Neutral
MACD
-0.98
Below its signal line
Bearish
Stochastic
16.4
Near the bottom of its range
Oversold
ADX (14)
19.8
No clear trend
Williams %R
-96.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-100.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−35.1%
Change over 10 sessions
Bearish
ATR (14)
$1.52
Typical daily range, 19.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BNTC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BNTC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow BNTC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BNTCHow many large options trades hit BNTC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BNTC in the last 90 days.
From SEC Form 4 filings by BNTC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BNTC is in one of them and how their past BNTC trades turned out.
Benitec is a biotechnology company in Hayward, California, that develops genetic medicines for rare diseases. Its lead product candidate, BB-301, is a gene therapy being tested for oculopharyngeal muscular dystrophy, a degenerative muscle disorder that affects swallowing, eyelids and limbs. The company's approach uses viral vectors to deliver genetic material that silences a harmful gene while replacing it with a working copy. Its intended users are patients with this condition, and it may work with larger drug companies on some programs.